Cargando…

Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine

BACKGROUND: Levodopa and dopamine agonists (dopamine replacement therapy [DRT]) are implicated in Parkinson's disease psychosis (PDP), but the relationship between DRT and neurotransmitter dysfunction inherent to PD remains unclear. OBJECTIVES: To examine the relationship between baseline stria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dave, Sonali, Weintraub, Daniel, Aarsland, Dag, ffytche, Dominic H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962668/ https://www.ncbi.nlm.nih.gov/pubmed/31970209 http://dx.doi.org/10.1002/mdc3.12851

Ejemplares similares

Light, sleep‐wake rhythm, and behavioural and psychological symptoms of dementia in care home patients: Revisiting the sundowning syndrome
por: Guu, Ta‐Wei, et al.
Publicado: (2022)

A Comparison of Cognitive Performance in Patients With Parkinson's Disease Psychosis According to Psychosis Severity: A Meta-Analysis
por: Gosse, Luca, et al.
Publicado: (2023)

A Preliminary Investigation of the Views of People With Parkinson's (With and Without Psychosis) and Caregivers on Participating in Clinical Trials During the Covid-19 Pandemic: An Online Survey
por: McGoohan, Katie, et al.
Publicado: (2020)

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2021)

Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
por: Oehrn, Carina R., et al.
Publicado: (2021)

Beyond Dopamine: Functional MRI Predictors of Responsiveness to Cognitive Behaviour Therapy for Psychosis
por: Kumari, Veena, et al.
Publicado: (2010)

Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
por: Zhang, Jinglin, et al.
Publicado: (2016)

Psychosis in Alzheimer’s Disease
por: Ballard, Clive, et al.
Publicado: (2020)

From Tones in Tinnitus to Sensed Social Interaction in Schizophrenia: How Understanding Cortical Organization Can Inform the Study of Hallucinations and Psychosis
por: ffytche, Dominic H., et al.
Publicado: (2014)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Mediating Effect of Mutuality on Health-Related Quality of Life in Patients with Parkinson's Disease
por: Karlstedt, Michaela, et al.
Publicado: (2018)

Revisiting the Role of Astrocytic MAOB in Parkinson’s Disease
por: Nam, Min-Ho, et al.
Publicado: (2022)

Diagnosis and management of Parkinson's disease dementia
por: Poewe, W, et al.
Publicado: (2008)

Bifrontal ECT for drug-induced psychosis in Parkinson's disease
por: Muralidharan, K., et al.
Publicado: (2011)

Psychosis in Parkinson's disease
Publicado: (2011)

Parkinson Disease Psychosis: Update
por: Friedman, J. H.
Publicado: (2013)

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive‐enhancing medications
por: Espay, Alberto J., et al.
Publicado: (2018)

Cognitive Interventions in Parkinson’s Disease: Where We Want to Go within 20 Years
por: Kalbe, Elke, et al.
Publicado: (2018)

Visual Hallucinations in the Psychosis Spectrum and Comparative Information From Neurodegenerative Disorders and Eye Disease
por: Waters, Flavie, et al.
Publicado: (2014)

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
por: Combs, Brianna L, et al.
Publicado: (2017)

It takes two—or more—to tango: Revisiting the role of dopamine transporter oligomerization
por: Gether, Ulrik, et al.
Publicado: (2021)

The Role of Dopamine Replacement on the Behavioural Phenotype of Parkinson’s Disease
por: Alobaidi, Hajar, et al.
Publicado: (2013)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Determinants of Dyadic Relationship and Its Psychosocial Impact in Patients with Parkinson's Disease and Their Spouses
por: Karlstedt, Michaela, et al.
Publicado: (2017)

Comparing Clinical Profiles in Alzheimer's Disease and Parkinson's Disease Dementia
por: Farlow, Martin R., et al.
Publicado: (2013)

Cycloid Psychosis: Perris Criteria Revisited
por: Yadav, Devender Singh
Publicado: (2010)

The effects of dopamine on digit span in Parkinson’s disease
por: Warden, Clara, et al.
Publicado: (2016)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
por: Rektorova, Irena, et al.
Publicado: (2014)

The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging
por: Rodriguez, Manuel, et al.
Publicado: (2014)

The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
por: Zhou, Zhi Dong, et al.
Publicado: (2022)

Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
por: Green, Holly, et al.
Publicado: (2019)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Petrova, Mariya, et al.
Publicado: (2015)

Revisiting hysterical psychosis: A case report
por: Barbosa, D., et al.
Publicado: (2021)

Delusional Infestation Secondary to the Dopamine Agonist Ropirinole in a Patient With Parkinson's Disease: A Case Report With an Outline of the Biology of Psychosis
por: Kesserwani, Hassan
Publicado: (2021)

Effects of Dopamine on Sensitivity to Social Bias in Parkinson's Disease
por: Djamshidian, Atbin, et al.
Publicado: (2012)

Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
por: Grogan, John P, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cen9h46fcmahk2ju5sugt6vdap